LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 148

Search options

  1. Book ; Conference proceedings: From discovery to clinical practice

    Conley, Barbara A.

    NCI-EORTC present 2nd International Meeting on Cancer Diagnostic ; an interactive workshop focused on practical methods for bringing promising prognostic and predictive markers from the research laboratory to the bedside ; June 26 - 29, 2002, Grand Hyatt Hotel, Washington, DC, USA ; abstracts

    (The international journal of biological markers ; 17, Suppl. 2)

    2002  

    Institution National Cancer Institute
    Event/congress International Meeting on Cancer Diagnostics (2, 2002, WashingtonDC)
    Author's details conference co-chairpersons Barbara A. Conley
    Series title The international journal of biological markers ; 17, Suppl. 2
    Collection
    Language English
    Size S63 S. : graph. Darst.
    Publisher Wichtig
    Publishing place Milano
    Publishing country Italy
    Document type Book ; Conference proceedings
    HBZ-ID HT013431190
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Article ; Online: Genomically guided cancer treatments: from "promising" to "clinically useful".

    Conley, Barbara A

    Journal of the National Cancer Institute

    2015  Volume 107, Issue 7

    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Biomarkers, Tumor/genetics ; Decision Support Techniques ; Drugs, Investigational/pharmacology ; Genomics ; Humans ; Mutation ; Neoplasms/drug therapy ; Neoplasms/genetics ; Precision Medicine/trends
    Chemical Substances Antineoplastic Agents ; Biomarkers, Tumor ; Drugs, Investigational
    Language English
    Publishing date 2015-07
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 2992-0
    ISSN 1460-2105 ; 0027-8874 ; 0198-0157
    ISSN (online) 1460-2105
    ISSN 0027-8874 ; 0198-0157
    DOI 10.1093/jnci/djv168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Multifaceted epigenetic regulation of porcine testicular aromatase.

    Berger, Trish / Vanselow, Jens / Conley, Alan / Almand, Tana Jo / Nitta-Oda, Barbara S

    Molecular and cellular endocrinology

    2021  Volume 541, Page(s) 111526

    Abstract: Testicular aromatase catalyzes the synthesis of estradiol, which contributes to regulation of porcine Sertoli cell proliferation and postpubertal maintenance of Sertoli cell numbers. Although aromatase enzymatic activity decreases with age and is ... ...

    Abstract Testicular aromatase catalyzes the synthesis of estradiol, which contributes to regulation of porcine Sertoli cell proliferation and postpubertal maintenance of Sertoli cell numbers. Although aromatase enzymatic activity decreases with age and is persistently reprogrammed by prepubertal treatment with the aromatase inhibitor letrozole, the molecular bases for regulation have not been identified. DNA methylation was examined as a potential regulatory mechanism using DNA from Leydig cells isolated from 16-, 40-, and 68-week-old boars and from 68- week-old littermates treated with the aromatase inhibitor, letrozole. Methylation levels of individual CpG dinucleotides located in the distal untranslated exon 1 of the relevant aromatase encoding gene, CYP19A3, were quite high in Leydig cell DNA, and increased further with maturity of boar (P < 0.05), while aromatase activity and transcript abundance decreased more than two-fold. However, reduced aromatase activity following letrozole treatment was not accompanied by altered DNA methylation. Testicular expression of miR378 was altered by prepubertal treatment with letrozole. The data provide evidence for two different epigenetic mechanisms that regulate aromatase expression and enzymatic activity in the boar testis.
    MeSH term(s) Animals ; Animals, Newborn ; Aromatase/genetics ; Aromatase/metabolism ; Aromatase Inhibitors/pharmacology ; Cells, Cultured ; Epigenesis, Genetic/drug effects ; Epigenesis, Genetic/physiology ; Gene Expression Regulation, Developmental/drug effects ; Gene Expression Regulation, Enzymologic/drug effects ; Letrozole/pharmacology ; Leydig Cells/drug effects ; Leydig Cells/metabolism ; Male ; Sertoli Cells/drug effects ; Sertoli Cells/metabolism ; Swine/genetics ; Swine/growth & development ; Testis/drug effects ; Testis/growth & development ; Testis/metabolism
    Chemical Substances Aromatase Inhibitors ; Letrozole (7LKK855W8I) ; Aromatase (EC 1.14.14.1)
    Language English
    Publishing date 2021-11-29
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 187438-x
    ISSN 1872-8057 ; 0303-7207
    ISSN (online) 1872-8057
    ISSN 0303-7207
    DOI 10.1016/j.mce.2021.111526
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Exfoliation Syndrome and Exfoliation Glaucoma in the Navajo Nation.

    Patil, Ayesha / Swiston, Cole / Wallace, Ryan T / Paulson, Chase / Conley, Matthew E / McCoy, Lori / Chaya, Craig / Wirostko, Barbara

    Vision (Basel, Switzerland)

    2022  Volume 6, Issue 4

    Abstract: 1) Background: Exfoliation syndrome (XFS) is a common cause of secondary open angle glaucoma. In 1971, Faulkner et al. estimated the prevalence of XFS among 50 Navajo Nation residents as 38%. Given that XFS can cause irreversible blindness secondary to ... ...

    Abstract (1) Background: Exfoliation syndrome (XFS) is a common cause of secondary open angle glaucoma. In 1971, Faulkner et al. estimated the prevalence of XFS among 50 Navajo Nation residents as 38%. Given that XFS can cause irreversible blindness secondary to glaucoma (XFG), this study aims to identify the current prevalence of XFS among Navajo Nation residents within the Four Corners region of the U.S. (2) Methods: A retrospective chart review was conducted from 2016 to 2021 for patients aged 18 and older. All patients with XFS or XFG diagnosed by slit lamp exam were identified through chart review. (3) Results: Of the 1152 patient charts available for review, eight patients (11 eyes) were diagnosed with XFS with three patients (4 eyes) demonstrating concomitant XFG. Within this XFS population, 50% of the patients identified as male, with a mean age of 73 years. The overall prevalence of XFS was 0.7% and the overall prevalence of XFG was found to be 0.26%. The rate of XFG among patients with XFS was 37.5%. (4) Conclusion: Compared to Faulkner's study of Navajo Nation residents in 1971, our findings show a considerably lower prevalence of XFS at 0.7%. We present the largest study to date of XFS among this population.
    Language English
    Publishing date 2022-10-03
    Publishing country Switzerland
    Document type Journal Article
    ISSN 2411-5150
    ISSN (online) 2411-5150
    DOI 10.3390/vision6040061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Abdominal aortic aneurysm and exfoliation syndrome: A literature review comparing single site findings.

    Patil, Ayesha / Conley, Matthew / Paulson, Chase / Pompoco, Christian / Wallace, Ryan / Swiston, Cole / Ritch, Robert / Curtin, Karen / Wirostko, Barbara

    Acta ophthalmologica

    2022  Volume 101, Issue 5, Page(s) 478–484

    Abstract: Several studies have suggested a possible relationship between exfoliation syndrome (XFS) and abdominal aortic aneurysm (AAA). A systematic literature review was undertaken to investigate this potential association. The systematic literature review was ... ...

    Abstract Several studies have suggested a possible relationship between exfoliation syndrome (XFS) and abdominal aortic aneurysm (AAA). A systematic literature review was undertaken to investigate this potential association. The systematic literature review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Clear definitions of XFS and AAA were used to identify eligible studies via an unrestricted search of the PubMed interface from 1979 to October 31st, 2021. After review, 876 citations were gathered and evaluated for inclusion, from which 22 articles were included. Of these 22, 16 were excluded because they did not assess the relationship between AAA and XFS or provide primary data. Ultimately, six studies were included in this literature review. Half of the studies explored AAA prevalence in a population with or without XFS, and the other half explored the opposite. Three studies supported XFS as a risk factor for the development of AAA, and the other three found this relationship to be inconclusive. This systematic review revealed inconsistent results regarding an association between AAA and XFS. A large database study including XFS and AAA patients would be useful in further determining if an association does in fact exist.
    MeSH term(s) Humans ; Exfoliation Syndrome/complications ; Exfoliation Syndrome/diagnosis ; Exfoliation Syndrome/epidemiology ; Risk Factors ; Aortic Aneurysm, Abdominal/complications ; Aortic Aneurysm, Abdominal/diagnosis ; Aortic Aneurysm, Abdominal/epidemiology ; Prevalence
    Language English
    Publishing date 2022-12-08
    Publishing country England
    Document type Systematic Review ; Journal Article ; Review
    ZDB-ID 2408333-1
    ISSN 1755-3768 ; 1755-375X
    ISSN (online) 1755-3768
    ISSN 1755-375X
    DOI 10.1111/aos.15307
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Clinical Application of Liquid Biopsies.

    Williams, P Mickey / Conley, Barbara A

    JAMA oncology

    2016  Volume 2, Issue 8, Page(s) 1003–1005

    MeSH term(s) Adenocarcinoma/diagnosis ; Adenocarcinoma/genetics ; Clinical Decision-Making ; DNA, Neoplasm/analysis ; DNA, Neoplasm/blood ; High-Throughput Nucleotide Sequencing ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/genetics ; Mutation ; Polymerase Chain Reaction/methods ; Precision Medicine ; Proto-Oncogene Proteins p21(ras)/genetics ; Receptor, Epidermal Growth Factor/genetics ; Sequence Analysis, DNA
    Chemical Substances DNA, Neoplasm ; KRAS protein, human ; EGFR protein, human (EC 2.7.10.1) ; Receptor, Epidermal Growth Factor (EC 2.7.10.1) ; Proto-Oncogene Proteins p21(ras) (EC 3.6.5.2)
    Language English
    Publishing date 2016-08-01
    Publishing country United States
    Document type Editorial
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2016.0240
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Oncology mental health providers' adaptation of an evidence-based intervention: A mixed-methods study.

    Conley, Claire C / Ryba, Marlena M / Brothers, Brittany M / Lo, Stephen B / Andersen, Barbara L

    Psycho-oncology

    2024  Volume 33, Issue 1, Page(s) e6272

    Abstract: Background: Adaptations are intentional modifications maximizing the fit of an evidence-based intervention (EBI) in new context. Little is known about EBI adaptation within psychosocial oncology. Guided by the Framework for Reporting Adaptations and ... ...

    Abstract Background: Adaptations are intentional modifications maximizing the fit of an evidence-based intervention (EBI) in new context. Little is known about EBI adaptation within psychosocial oncology. Guided by the Framework for Reporting Adaptations and Modifications-Enhanced (FRAME), this mixed-methods study describes oncology mental health providers' planned adaptations to a psychosocial oncology EBI and examines the relationship between planned adaptations and longitudinal EBI usage.
    Methods: Providers (N = 128) were social workers (47%) and psychologists (40%) practicing in community settings (44%) or academic medical centers (41%). They attended a 3-day training on a multicomponent psychosocial oncology EBI, the Biobehavioral Intervention (BBI). During training, providers prepared an "adaptation plan" describing necessary adaptations to BBI and rationales for change. Qualitative data from adaptation plans were analyzed using directed content analysis. Linear mixed models examined the relationship between adaptation characteristics (number, similarity to the manualized BBI) and EBI usage across 12 months post-training.
    Results: Three sets of qualitative themes reflecting FRAME elements emerged: (1) content modifications (e.g., shortening/condensing, selecting elements, adding/removing elements); (2) contextual changes (e.g., alternative group formats); and (3) reasons for adaptations (e.g., organization/setting, provider, and recipient factors). Neither number of adaptations nor adaptation similarity were associated with BBI usage across 12 months post-training.
    Conclusions: To our knowledge, this study is the first to characterize oncology mental health providers' planned adaptations to a psychosocial oncology EBI. Planned adaptations did not increase usage, but importantly they did not decrease usage. The adaptation process enabled providers to make thoughtful adaptation choices, with implementation successful irrespective of setting constraints.
    MeSH term(s) Humans ; Evidence-Based Medicine ; Mental Health ; Medical Oncology ; Social Workers
    Language English
    Publishing date 2024-01-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 1118536-3
    ISSN 1099-1611 ; 1057-9249
    ISSN (online) 1099-1611
    ISSN 1057-9249
    DOI 10.1002/pon.6272
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Wastewater treatment plants as a source of microplastics to an urban estuary: Removal efficiencies and loading per capita over one year.

    Conley, Kenda / Clum, Allan / Deepe, Jestine / Lane, Haven / Beckingham, Barbara

    Water research X

    2019  Volume 3, Page(s) 100030

    Abstract: Wastewater treatment plants serve to collect and treat wastes that are known to include microplastic (MP; synthetic polymer materials <5 mm in size) and other small anthropogenic litter as particles, fibers and microbeads. Here, we determined the ... ...

    Abstract Wastewater treatment plants serve to collect and treat wastes that are known to include microplastic (MP; synthetic polymer materials <5 mm in size) and other small anthropogenic litter as particles, fibers and microbeads. Here, we determined the microplastic loads and removal efficiencies of three wastewater treatment plants (WWTPs) with different treatment sizes, operations and service compositions discharging to Charleston Harbor, South Carolina, USA over the course of a year. Overall, we found that MP concentrations (counts per L) varied within a factor of 2.5 in influent and 4.8 in effluent at each WWTP, and that neither concentrations nor removal efficiencies demonstrated a seasonal trend. The largest wastewater treatment plant in the study, which also employed primary clarification, had the highest MP removal efficiency of 97.6 ± 1.2%. The other two smaller facilities had average removal efficiencies of 85.2 ± 6.0% and 85.5 ± 9.1%. We demonstrate through source modeling that microplastic fiber loads in influent were consistent with service area populations laundering textiles given previously published rates of microplastic generation in washing machines. Using measured WWTP flow rates and MP counts, we find a combined load of MPs leaving all three WWTPs with discharged effluent totaling 500-1000 million MPs per day. We estimate from this the emission of 0.34-0.68 g MP per capita per year in treated wastewater, which may only account for <0.1% of plastic debris input to this metropolitan area's surface waters on an annual mass basis when land-based (mis)managed plastic waste sources are also considered. However, the potential for sorption of chemicals present in wastewater to microplastics and their small size, which confers immediate bioaccessibility, may present unique toxicological risks for microplastics discharged from WWTPs.
    Language English
    Publishing date 2019-04-10
    Publishing country England
    Document type Journal Article
    ISSN 2589-9147
    ISSN (online) 2589-9147
    DOI 10.1016/j.wroa.2019.100030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Molecular analysis for therapy choice: NCI MATCH.

    Conley, Barbara A / Doroshow, James H

    Seminars in oncology

    2014  Volume 41, Issue 3, Page(s) 297–299

    MeSH term(s) Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor/analysis ; Decision Making ; Humans ; Molecular Targeted Therapy ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/metabolism
    Chemical Substances Antineoplastic Agents ; Biomarkers, Tumor
    Language English
    Publishing date 2014-06
    Publishing country United States
    Document type Editorial
    ZDB-ID 189220-4
    ISSN 1532-8708 ; 0093-7754
    ISSN (online) 1532-8708
    ISSN 0093-7754
    DOI 10.1053/j.seminoncol.2014.05.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.

    Chen, Monica F / Song, Zihe / Yu, Helena A / Sequist, Lecia V / Lovly, Christine M / Mitchell, Edith P / Moscow, Jeffrey A / Gray, Robert J / Wang, Victoria / McShane, Lisa M / Rubinstein, Larry V / Patton, David R / Williams, P Mickey / Hamilton, Stanley R / Umemura, Yoshie / Tricoli, James V / Conley, Barbara A / Arteaga, Carlos L / Harris, Lyndsay N /
    O'Dwyer, Peter J / Chen, Alice P / Flaherty, Keith T

    JCO precision oncology

    2024  Volume 8, Page(s) e2300454

    Abstract: Purpose: The National Cancer Institute Molecular Analysis for Therapy Choice trial is a signal-finding genomically driven platform trial that assigns patients with any advanced refractory solid tumor, lymphoma, or myeloma to targeted therapies on the ... ...

    Abstract Purpose: The National Cancer Institute Molecular Analysis for Therapy Choice trial is a signal-finding genomically driven platform trial that assigns patients with any advanced refractory solid tumor, lymphoma, or myeloma to targeted therapies on the basis of next-generation sequencing results. Subprotocol E evaluated osimertinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with
    Methods: Eligible patients had
    Results: A total of 19 patients were enrolled: 17 were evaluable for toxicity and 13 for efficacy. The median age of the 13 included in the efficacy analysis was 63 years, 62% had Eastern Cooperative Oncology Group performance status 1, and 31% received >three previous systemic therapies. The most common tumor type was brain cancers (54%). The ORR was 15.4% (n = 2 of 13; 90% CI, 2.8 to 41.0) and 6-month PFS was 16.7% (90% CI, 0 to 34.4). The two confirmed RECIST responses were observed in a patient with neuroendocrine carcinoma not otherwise specified (
    Conclusion: In this pretreated cohort, osimertinib did not meet the prespecified end point threshold for efficacy, but responses were seen in a neuroendocrine carcinoma with an
    MeSH term(s) United States ; Humans ; Middle Aged ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Carcinoma, Non-Small-Cell Lung/genetics ; ErbB Receptors/genetics ; National Cancer Institute (U.S.) ; Antineoplastic Agents/adverse effects ; Protein Kinase Inhibitors/adverse effects ; Mutation ; Carcinoma, Neuroendocrine/drug therapy ; Acrylamides ; Aniline Compounds ; Indoles ; Pyrimidines
    Chemical Substances osimertinib (3C06JJ0Z2O) ; ErbB Receptors (EC 2.7.10.1) ; Antineoplastic Agents ; Protein Kinase Inhibitors ; Acrylamides ; Aniline Compounds ; Indoles ; Pyrimidines
    Language English
    Publishing date 2024-04-09
    Publishing country United States
    Document type Clinical Trial, Phase II ; Journal Article
    ISSN 2473-4284
    ISSN (online) 2473-4284
    DOI 10.1200/PO.23.00454
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top